(Q33843646)

29 July 2017

1 reference

title

Hormone replacement therapy and coronary heart disease. A new debate (English)

1 reference

Hormone Replacement Therapy

29 July 2017

main subject

1 reference

Kuller LH

1

1 reference

29 July 2017

publication date

1 January 2000

1 reference

Medical Clinics of North America

29 July 2017

published in

1 reference

29 July 2017

volume

84

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

181-98, ix-x

1 reference

Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Inflammation and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Guidelines for counseling postmenopausal women about preventive hormone therapy. American College of Physicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Hormone replacement therapy, heart disease, and other considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Coronary heart disease mortality and adjuvant tamoxifen therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Hormone replacement therapy, inflammation, and hemostasis in elderly women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Predominance of aortic calcification as an atherosclerotic manifestation in women: the Reykjavik study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Postmenopausal hormone therapy and mortality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Effect of hormone replacement therapy on non-invasive cardiovascular haemodynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Interleukin-6 and the acute phase response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Postmenopausal estrogens and risk of myocardial infarction in diabetic women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Use of hormone replacement therapy by postmenopausal women in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Hysterectomy, oophorectomy, and heart disease risk factors in older women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Aging and cardiovascular disease. Use of subclinical measurements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Lifetime risk of developing coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Short-term predictors of incident stroke in older adults. The Cardiovascular Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Prior to use of estrogen replacement therapy, are users healthier than nonusers?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Association of sex hormones and adiposity with plasma levels of fibrinogen and PAI-1 in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

No association of menopause and hormone replacement therapy with carotid artery intima-media thickness. Atherosclerosis Risk in Communities (ARIC) Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Lipoprotein(a) as a determinant of coronary heart disease in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Hormone replacement therapy and risk of non-fatal stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Drug's link to genes reveals estrogen's many sides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Hormone replacement therapy and heart disease prevention: experimentation trumps observation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Incidence of stroke and myocardial infarction in women of reproductive age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

The Women’s Health Initiative Memory Study (WHIMS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Effects of estrogens on macrophage foam cells: a potential target for the protective effects of estrogens on atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Sudden unexpected death in women: biologic and psychosocial origins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Effects of cholesterol lowering on the progression of coronary atherosclerosis in women. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) substudy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Regression of Atherosclerosis in Female Monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Cigarette smoking and the development and progression of aortic atherosclerosis. A 9-year population-based follow-up study in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

George Lyman Duff Memorial Lecture. Multifactorial etiology of hypercholesterolemia. Implications for prevention of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Risk factors for cardiovascular disease among women

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970213-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(05)70213-3

1 reference

29 July 2017

1 reference